Endogenous type I interferons as a defense against tumors

Cytokine and Growth Factor Reviews

Volumn 13, Issue 2, 2002, Pages 111-118

  Gresser, Ion ^a,c   Belardelli, Filippo ^b  

^a INSTITUT CURIE   (France)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c INSERM   (France)

Author keywords

Endogenous type I interferon; Immune surveillance; Tumor

Indexed keywords

INTERFERON; INTERFERON ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL; CANCER GRAFT; CANCER INHIBITION; CANCER INVASION; CANCER MODEL; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; DEFENSE MECHANISM; ERYTHROLEUKEMIA CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; METABOLISM; METASTASIS; MOUSE; MOUSE STRAIN; NEOPLASM; NONHUMAN; NUDE MOUSE; PHYSIOLOGY; REVIEW; TUMOR CELL; TUMOR GROWTH; TUMOR RESISTANCE; C3H MOUSE; C57BL MOUSE; CBA MOUSE;

DNA VIRUSES; MURINAE; MUS MUSCULUS;

ANIMALS; HUMANS; INTERFERON TYPE I; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036005887     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(01)00035-1     Document Type: Article

References (62)

1. The concept of immunological surveillance
2. Discussion
3. A fresh look at tumor immunosurveillance and immunotherapy
4. Tumors of the immunocompromised patient
5. Immunodepression and malignancy
6. Increased survival in mice inoculated with tumor cells and treated with interferon preparations
7. How does interferon inhibit tumor growth?
8. Interferon treatment of human neoplasia
9. Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus
10. Injection of mice with antibody to mouse interferon α/β decreases the level of 2-5′-oligo-adenylate synthetase in peritoneal macrophages
11. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection
12. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, moloney sarcoma, vesicular stomatitis, newcastle disease, and influenza viruses
13. Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice
14. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus
15. HIV-infected tumor xenografts as an vivo model for antiviral therapy. Role of interferon α/β in the restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells
16. Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors
17. Interferon and Cell division. IX. Interferon-resistant L1210 cells: Characteristics and origin
18. Isolation of interferon-resistant variants of Friend erythroleukemia cells: Effect of interferon and ouabain
19. Role of endogenous α/β interferon in the selection of virus nonproducer Friend leukemia cells after serial intraperitoneal passages in syngeneic mice
20. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells
21. Antibody to mouse interferon α/β abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice
22. Purification of mouse interferon by sequential affinity chromatography on poly(U)- and antibody-agarose columns
23. Monoclonal antibody to murine γ interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities
24. Importance of interferon in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver
25. Current concepts: Immunology. Transplantation immunology
26. Histocompatibility genes in the mouse. II. Production and analysis of isogenic resistant lines
27. Histocompatibility genes of mice. III. H-1 and H-4, two histocompatibility loci in the first linkage group
28. Differential behavior of transplanted mouse lymphoma lines in genetically compatible homozygous and Fl hybrid mice
29. Production and role of interferon in physiological conditions
30. The physiological interferon response
31. Antitumor effects of interferons past, present and future
32. Antitumor effects of interferon
33. Wherefore IFN?
34. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells
35. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanisms
36. How does interferon inhibit tumor growth?
37. Inhibition of angiogenesis by interferons: Effects on tumor and lymphocyte-induced vascular responses
38. Microvascular injury in the pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice
39. Interaction of IFN α/β with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice
40. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases
41. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon α/β treatment in mice
42. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo
43. Interferon inhibits the generation of allospecific suppressor T lymphocytes
44. Induction of bystander T cell proliferation by viruses and type I interferon in vivo
45. The essential role of endogenous IFN α/β in the antimetastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells
46. Cellular immunity against tumor antigens
47. Allogeneic inhibition of transplanted tumor cells
48. Demonstration of syngeneic preference in vitro
49. Early effect of interferon on mouse leukemia cells cultivated in a chemostat
50. Enhancement by interferon of the expression of surface antigens on murine leukemia L120 cells
51. Enhancement by interferon of the expression of histocompatibility antigens of mouse lymphoid cells in vitro
52. Enhanced NK cell activity in mice injected with interferon and interferon inducers
53. Augmentation of mouse natural killer cell activity by interferon and interferon inducers
54. Stimulation of genetic resistance to marrow grafts in mice by interferon α/β
55. The neglected role of type I interferon in the T cell response: Implications for its clinical use
56. Role of interferons and other cytokines in the regulation of the immune response
57. Interferon messenger RNA is produced constitutively in the organs of normal individuals
58. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection
59. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
60. Functional role of type I and type II interferons in antiviral defense